Agilon Health AGL Cash Flow Statement (2020-2026)

NYSE AGL
$86.34 -1.04 (-1.19%)
As of: Sep 3, 2026 · 3:59 PM EDT
Reported Financials

Agilon Health Quarterly Cash Flow Statement

Periods 26 quarters
Latest Jun 2026

Agilon Health reported cash from operations of -$57.30M and free cash flow of -$60.74M for the quarter ended Jun 2026, down 63.3% year over year. This cash flow statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-35.88M-56.47M1.16M-20.72M-30.74M-56.58M15.96M-16.80M-31.48M-230.48M-6.03M-30.66M-117.61M-105.79M12.11M-104.37M-110.21M-188.88M48.92M17.96M
Share-based CompensationStock Comp.
11.96M4.41M3.97M6.55M7.91M9.95M13.67M19.57M20.74M15.52M16.91M18.21M13.26M2.28M16.72M15.38M7.50M9.52M6.25M23.83M
Cash from OperationsCash from Ops.
-19.14M-48.90M-23.23M-60.26M2.65M-49.96M-60.81M-21.20M-13.02M-61.17M-47.78M-18.72M-7.70M16.42M-31.99M-35.09M-18.15M-20.54M23.73M-57.30M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
3.94M3.64M3.37M3.04M3.45M3.91M4.19M5.51M5.31M5.15M5.84M5.91M6.22M6.49M6.88M7.32M7.43M6.97M6.79M6.86M
Change in Working Capital
Other Working Capital ChangesOther WC Changes
-2.59M30.25M46.31M-16.95M91.47M20.49M-6.27M63.34M3.98M-92.14M38.79M-52.88M-92.72M8.43M113.99M
Investing Activities
Capital ExpendituresCapex
2.52M3.40M4.05M4.46M3.43M3.49M3.72M4.09M4.09M3.93M3.14M3.31M3.53M3.27M3.85M3.25M3.17M2.97M3.10M3.45M
Acquisitions
44.37M0.11M0.77M
Divestments
1.30M0.50M2.19M
Change in Acquisitions & DivestmentsChange Acquisitions
0.68M3.60M10.85M37.42M28.54M68.73M36.62M30.15M74.52M41.22M51.08M40.09M35.31M90.03M35.19M33.34M22.40M24.22M
Cash from Investing ActivitiesCash from Investing
-11.56M-2.60M-8.87M-296.61M-130.94M-7.97M-50.81M20.03M-11.03M-2.20M51.44M18.22M46.56M23.67M-23.09M70.46M18.66M22.58M19.27M19.91M
Financing Activities
Other financing activitiesOther financing
14.76M-14.76M
Cash from Financing ActivitiesCash from Financing
0.90M10.42M13.51M4.31M9.11M1.13M8.34M-202.04M1.41M-0.84M0.56M-1.71M-1.41M-0.02M-0.16M-2.58M-0.24M-0.02M-5.15M4.63M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
1.45M0.99M-0.16M-0.16M-2.58M-0.24M-0.04M4.63M
Net Equity Issued and RepurchasedNet Equity Issued
1.05M16.48M14.76M5.56M10.36M2.38M9.59M-0.79M2.66M0.41M1.81M-0.46M-0.16M-0.02M-0.16M
Additional items
Change in Cash
-29.81M-41.08M-18.60M-352.56M-119.18M-56.80M-103.29M-203.21M-22.64M-64.21M4.22M-2.21M37.45M40.07M-55.24M32.79M0.27M2.03M37.85M-32.76M
Free Cash FlowFCF
-21.66M-52.30M-27.28M-64.72M-0.79M-53.45M-64.53M-25.30M-17.11M-65.10M-50.91M-22.03M-11.24M13.15M-35.84M-38.34M-21.33M-23.50M20.63M-60.74M
Net Cash FlowNCF
-29.81M-41.08M-18.60M-352.56M-119.18M-56.80M-103.29M-203.21M-22.64M-64.21M4.22M-2.21M37.45M40.07M-55.24M32.79M0.27M2.03M37.85M-32.76M